BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6111814)

  • 1. Determination of pharmacodynamics of psychotropic drugs by psychometric analysis.
    Grünberger J; Saletu B
    Prog Neuropsychopharmacol; 1980; 4(4-5):417-34. PubMed ID: 6111814
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients.
    Saletu B; Grünberger J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):45-58. PubMed ID: 419165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.
    Saletu B; Grünberger J; Linzmayer L; Stadler R
    Arzneimittelforschung; 1980; 30(3):513-8. PubMed ID: 6104496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychomotor function and psychoactive drugs.
    Hindmarch I
    Br J Clin Pharmacol; 1980 Sep; 10(3):189-209. PubMed ID: 7002180
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.
    Saletu B; Grünberger J; Flener R; Linzmayer L; Sieroslawski H
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):810-21. PubMed ID: 827426
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of alcohol and other drugs on psychomotor performance and cognitive function.
    Hindmarch I; Kerr JS; Sherwood N
    Alcohol Alcohol; 1991; 26(1):71-9. PubMed ID: 1854375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
    Saletu B; Grünberger J; Cepko H
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drugs: evaluation of mutagenic effect.
    Balbi A; Muscettola G; Staiano N; Martire G; De Lorenzo F
    Pharmacol Res Commun; 1980 May; 12(5):423-31. PubMed ID: 6108571
    [No Abstract]   [Full Text] [Related]  

  • 9. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
    Saletu B; Grünberger J
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of diphenylhydantoin in relation to plasma levels. Behavioral and psychophysiological studies.
    Ideström CM; Schalling D; Carlquist U; Sjöqvist F
    Psychol Med; 1972 May; 2(2):111-20. PubMed ID: 5034108
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
    Saletu B; Grünberger L; Linzmayer L; Wittek R; Stöhr H
    Wien Klin Wochenschr; 1983 Jul; 95(14):481-93. PubMed ID: 6356628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of psychotherapeutic agents in rats chronically dosed with alpha-acetylmethadol.
    Maickel RP; Lambert CS; Braude MC; Zabik JE
    Commun Psychopharmacol; 1978; 2(1):45-50. PubMed ID: 26496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pupillometry in psychopharmacologic experiments].
    Grünberger J; Linzmayer L; Cepko H; Saletu B
    Arzneimittelforschung; 1986; 36(1):141-6. PubMed ID: 3954817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychologic contribution to the differentiation of the tranquilizing or sedative effect of a psychoactive drug].
    Quatember R; Maly J
    Fortschr Med; 1983 May; 101(18):855-60. PubMed ID: 6862347
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiological and psychological effects of clorazepate in man.
    Lader MH; Curry S; Baker WJ
    Br J Clin Pharmacol; 1980 Jan; 9(1):83-90. PubMed ID: 6101956
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of centrally acting drugs on flicker fusion frequency].
    von Littrow C; Feller K; Graupner K; Kálmán E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():54-7. PubMed ID: 829636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
    Saletu B; Grünberger J; Rajna P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice.
    Shah NS
    Biochem Pharmacol; 1976 Mar; 25(5):591-7. PubMed ID: 8055
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of psychotropic drugs of different classes injected in super small doses].
    Molodavkin GM; Voronina TA; Cherniavskaia LI; Burlakova EB
    Radiats Biol Radioecol; 2003; 43(3):287-90. PubMed ID: 12881980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.